Exane Derivatives’s Momentive Global Inc. Common Stock MNTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$62 Buy
+7
New +$94 ﹤0.01% 737
2022
Q1
Sell
-7
Closed -$148 1097
2021
Q4
$148 Sell
7
-126
-95% -$2.77K ﹤0.01% 856
2021
Q3
$2.61K Sell
133
-3,083
-96% -$62.6K ﹤0.01% 784
2021
Q2
$66.9K Buy
+3,216
New +$62.3K 0.02% 600

Other funds holding MNTV

Exane Derivatives's MNTV Position: Q2 2022 in Review

Exane Derivatives opened a new position in Momentive Global Inc. Common Stock (MNTV) in Q2 2022: 7 shares worth $62. The stake represents ﹤0.01% of the portfolio and ranks #737 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in MNTV as recently as Q4 2021.

Exane Derivatives first reported a position in MNTV in Q2 2021 and has held it in 4 quarters since. The position peaked at $66.9K in Q2 2021. 210 funds tracked by Wall St. Rank hold MNTV as of Q2 2022.

  • Exane Derivatives held 7 shares of Momentive Global Inc. Common Stock worth $62 as of Q2 2022.
  • Momentive Global Inc. Common Stock was a new Exane Derivatives position in Q2 2022.
  • Momentive Global Inc. Common Stock made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #737 holding.
  • Exane Derivatives first reported a position in Momentive Global Inc. Common Stock in Q2 2021 and has held it in 4 quarters since.
  • Exane Derivatives's Momentive Global Inc. Common Stock position peaked at $66.9K in Q2 2021.
  • 210 funds tracked by Wall St. Rank held Momentive Global Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.